MAG attenuated inflammation by down-regulating the HMGB1/MyD88/NF-κB pathway and NLRP3 inflammasome, thereby alleviating the “M1” polarized macrophage-mediated in-vitro IDD model (Figure 7). The gene discussed is MYD88; the disease is intervertebral disk degenerative disorder.